BENZOXAZOLE: THE MOLECULE OF DIVERSE PHARMACOLOGICAL IMPORTANCE
Keywords:
Benzoxazole, Synthesis, Pharmacological activityAbstract
Benzoxazole nucleus is one of the most important heterocyclic compounds exhibiting remarkable pharmacological activities. The present review provides a broad overview of the synthesis and pharmacological activities such as antimycobacterial, anticonvulsant, anti-inflammatory, anticancer, DNA topoisomerase inhibitor, cholesterol ester transfer protein inhibitor and miscellaneous activities.
Â
Downloads
References
Delgado JN, Remers WA. Wilson and Giswold’s Textbook of Organic Chemistry Medicinal and Pharmaceutical Chemistry. 10th ed. Philadelphia: Lipincott Raven; 1998.
Dinakaran VS, Fused pyrimidines. The heterocycle of diverse biological and pharmacological significance. Der Pharm Chem 2012;4(1):255-65.
Pratyusha C, Poornima G, Rani KS, Krishnaveni A, Brahmaiah B. An overview on synthesis and biological activity of pyrimidines. Int J Pharm Rev Res 2013;13(2):86-90.
Wang L, Zhang P, Zhang X, Zang YLi. Synthesis and biological evaluation of a novel series of 1, 5-benzothiazepine derivatives as potential antimicrobial agents. Eur J Med Chem 2009;44:2815-21.
Moghaddam FM, Bardajee GR, Ismaili H, Taimoory SMD. Facile and efficient one pot protocol for the synthesis of benzoxazole and benzthiazole derivative using molecular iodine as a catalyst. Syn Comm 2006;36:2543.
Rohet F, Rubat C, Coudert P, Couquelet J. Synthesis and analgesic effects of 3-substituted 4, 6-diarylpyridazine derivatives of the arylpiperazine class. Bioorg Med Chem 1997;5:655-9.
Unlu S, Baytas SN, Kupeli E, Yesilada E. Studies on novel 7-acyl-5-chloro-2-oxo-3H-benzoxazole derivatives as potential analgesic and antiinflammatory agents. Arch Pharm 2003;336:310-21.
Viaud MC, Jamoneau P, Flouzat C, Espiard JG, Pfeiffer B, Renard P, et al. N-Substituted oxazolo[5,4-b]pyridin-2(1H)-ones: a new class of non-opiate antinociceptive agents. J Med Chem 1995;38:1278-86.
Lokhwani P, Nagori BP, Batra N, Goyal A, Gupta S. Benzoxazole: The molecule of diverse biological activity. J Pharmacol Online 2011;1:236-45.
Yang YH, Shi M. Selective synthesis of benzoxazoles and N-(2-hydroxyaryl) pyrrolidin-2-ones from corresponding cyclopropylamides with PPh3/CX4. Tetrahedron Lett 2006;62:2420.
Do HQ, Daugulis O. Copper catalyzed arylation of heterocycle C−H bonds. J Amer Chem Soc 2007;129:12404.
Maradolla MB, Allam SK, Mandha A, Chandramouli GVP. One pot synthesis of benzoxazoles, benzthiazoles and benzimidazoles from carboxylic acids using ionic liquids. Arkivoc 2008;15:42-6.
Yoshida S, Shiokawa S, Kawano K, Ito T, Murakami H, Suzuki H, et al. Orally active benzoxazole derivative as 5-HT3 receptor partial agonist for treatment of diarrhoea-predominant irritable bowel syndrome. J Med Chem 2005;48:7075-9.
Prakash O, Pannu K, Kumar A. Synthesis of some new 2-(3-Aryl-1-phenyl-4-pyrazolyl)-benzoxazoles using hypervalent iodine mediated oxidative cyclization of schiff’s bases. J Molecule 2006;11:43-8.
Temiz AO, Ozdemira A, Yalcin I, Yildiz I, Aki-Senera E. Synthesis and Antimicrobial Activity of some 5-[2-(morpholin-4-yl)acetamido] and/or 5-[2-(4-substituted piperazin-1-yl)acetamido]-2-(p-substituted phenyl) benzoxazoles. Arch Pharm Chem Life Sci 2005;338:105−11.
Norrby R. Linezolid-A review of the first oxazolidinone. Expert Opinion Pharmacother 2001;2(2):293-302.
Tomasz AN. Multiple-antibiotic resistant pathogenic bacteria. New Eng J Med 1994;330:1247-9.
Yalcin I, Sener E, Temiz O, Oren I. Synthesis and structure-activity relationships of some 2,5-disubstituted benzoxazoles and benzimidazoles as antimicrobial agents. IL Farmaco 1997;52(2):99-103.
Ertan T, Yildiz I, Tekiner-gulbas B, Bolelli K, Temiz-Arpacıa O, Yalcin I, et al. Synthesis biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents. Eur J Med Chem 2009;44:501-10.
Zitouni GT, Demirayak S, Ozdemir A, Kaplancikli ZA, Yıldız MT. Synthesis of some 2-[(benzoxazole-2-yl)thioacetylamino] thiazole derivatives and their antimicrobial activity and toxicity. Eur J Med Chem 2004;39(3):267–72.
Temiz-Arpaci O, Yildiz I, Ozkan S, Kaynak F, Sener E, Yalcin I. Synthesis and biological activity of some new benzoxazoles. Eur J Med Chem 2008;43:1423-31.
Kim BJ, Kim J, Kim YK, Choi SY, Choo HYP. Synthesis of benzoxazole amides as novel antifungal agents against Malassezia furfur. Bull Korean Chem Soc 2010;31:1270-5.
Ramalingan C, Balasubramanian S, Kabilan S, Vasudevan M. Synthesis and study of antibacterial and antifungal activities of novel 1-[2-(benzoxazol-2-yl)ethoxy]-2,6 diarylpiperidin-4-ones. Eur J Med Chem 2004;39:527–33.
Elnima E, Zubair MU, Badr AA. Antibacterial and antifungal activities of benzimidazole and benzoxazole derivatives. Antimicrob Agents Chemother 1981;19(1):29-32.
Ozden O, Atabey D, Yıldız S, Goker H. Synthesis, potent anti-staphylococcal activity and QSARs of some novel 2-anilinobenzazoles. Eur J Med Chem 2008;43:1390-402.
Vinsova J, Cermakova K, Tomeckova A, Ceckova M, Jampilek J, Cermak P, et al. Highly lipophilic benzoxazoles with potential antibacterial activity. J Molecule 2005;10:783-93.
Kliomesova V, Koci J, Waisser K, Kaustova J, Mollmann U. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents. Eur J Med Chem 2009;44(5):2286-93.
Singh G, Kaur M, Mohan C, Prashar S. Synthesis and antimicrobial activity of benzoxazole derivatives. Indo Am J Pharm Res 2013;3(8):6113-8.
Jayanna ND, Vagdevi HM. Dharshan JC, Prashith TR, Hanumanthappa BC, Gowdarshivannanavar BC. Synthesis and biological evaluation of novel 5,7-dichloro-1,3-benzoxazole derivatives. J Chem 2013;1-9.
Pujar GV, Synesh C, Purohit MN, Srinivasalu N, Udupi RH. Synthesis, anticonvulsant and antibacterial activities of some novel pyrrolines derived from benzaxazole and benzimidazoles. Ind J Hetero Chem 2008;17:387-8.
Siddiqui N, Sarafaroz M, Alam M, Ahsan W. Synthesis, anticonvulsant and neurotoxicity evaluation of 5-Carbomethoxybenzoxazole derivatives. Acta Polo Pharm Drug Res 2008;65(4):449-55.
Wei CX, Guan LP, Jia JH, Chai KY, Quan ZS. Synthesis of 2-substituted-6-(4H-1,2,4-triazol-4-yl)benzo[d]oxazoles as potential anticonvulsant agents. Arch Pharmacal Res 2009;1:23-31.
Dannhardt G, Kiefer W. Cyclooxygenase inhibitors-current status and future prospects. Eur J Med Chem 2001;36:109.
Paramashivappa P, Kumar P, Subba Rao PV, Srinivas Rao A. Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors. Bioorg Med Chem Lett 2003;13:657-60.
Ampati S, Vidyasagar JV, Swathi K, Sarangapani M. Synthesis and in vitro evaluation of novel benzoxazole derivatives as specific cyclooxygenase–2 inhibitors. J Chem Pharm Res 2010;2(2):213-9.
Srinivas A, Sagar JV, Sarangapani M. Design, synthesis and biological evaluation of benzoxazole derivatives as cyclooxygensase-2 inhibitors. Int J Pharm Sci 2010;2(1):7-12.
Sondhi MS, Singh N, Kumar A, Lozach A, Meijer L. Synthesis, anti-inflammatory, apnalgesic and kinase(CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of banzimidazole/ benzoxazole derivatives and some schiff’s bases. Bioorg Med Chem 2006;14:3758–65.
Koksal M, Gokhan N, Kupeli E, Yesilada E, Erdogan H. Analgesic and anti-inflammatory activities of some new mannich bases of 5-nitro-2-benzoxazolinones. Arch Pharm Res 2007;30:19-424.
Safak C, Erdogan H, Palaska E, Sunal R, Duru S. Synthesis of 3-(2-pyridylethyl)benzoxazolinone derivatives: potent analgesic and antiinflammatory compounds inhibiting prostaglandin E2. J Med Chem 1992;35(7):1296-9.
Lesyk R, Vladzimirska O, Holota S, Zaprutko L, Gzella A. New 5-substituted thiazolo[3,2-b][1,2,4]triazol-6-ones: synthesis and anticancer evaluation. Eur J Med Chem 2007;42:641.
Murty MSR, Ram KR, Rao RV, Yadav JS, Rao JV, Cheriyan VT, et al. Synthesis and prelimnary evaluation of 2-substituted-1,3-benzoxazole and 3-[(3-substituted)propyl]-1,3-benzoxazol-2(3H)-one derivatives as potent anticancer agents. J Med Chem Res 2011;20:576-86.
Kamal A, Reddy KS, Khan MNA, Shetti R, Ramaiah MJ, Pushpavalli SNC, et al. Synthesis, DNA-binding ability and anticancer activity of benzthiazole/benzoxazole-pyrrolo[2,1-c][1,4]benzodiazepine conjugates. Bioorg Med Chem 2010;18:4747–61.
Akbay A, Oren I, Arpaci OT, Sener EA, Yalcin I. Synthesis and HIV-1 reverse transcriptase inhibitor activity of some 2, 5, 6-substituted benzoxazole, benzimidazole, benzothiazole and oxazolo(4,5-b)pyridine derivatives. Arzneim Forsch Drug Res 2003;53(4):266-71.
Oksuzoglu E, Gulbas BT, Alper S, Arpaci OT, Ertan T, Yildiz I, et al. Some benzoxazoles and benzimidazoles as DNA topoisomerase I and II inhibitors. J Enz Inhib Med Chem 2008;23(1):37-42.
Smith CJ, Ali Chen L, Hammonda ML, Anderson MS, Chen Y, Eveland SS, et al. 2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety. Bioorg Med Chem Lett 2010;20:346–9.
Hunt JA, Gonzalez S, Kallashi F, Hammond ML, Pivnichny JV, Tong X, et al. 2-Arylbenzoxazoles as CETP inhibitors: substitution and modification of the alpha-alkoxyamide moiety. Bioorg Med Chem Lett 2010;20:1019–22.
Youssef MA, Sherif SMA, Elkady AMA, Hamouda SES. Synthesis of some new benzoxazole acetonitrile derivatives and evaluation of their herbicidal efficiency. J Am Sci 2010;12(6):1080-9.
Potasman MH, Bready J, Coxon A, Dipetro L, Deorr N. Design synthesis and evaluation of orally active benzimidazole and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors. J Med Chem 2007;50:4351-73.
Hausner HS, Alagille D, Koren AO, Amici L, Staley JK, Cosgrove KP, et al. Synthesis of 5-and 6-substituted 2-(4-dimethylaminophenyl)-1,3-benzoxazoles and their in vitro and in vivo evaluation as imaging agents for amyloid plaque. Bioorg Med Chem 2009;19:543–5.
Swahn BM, Wensbo D, Sandell J, Sohn D, Slivo C, Pyring D, et al. Synthesis and evaluation of 2-pyridylbenzothiazole, 2-pyridylbenzoxazole and 2-pyridylbenzofuran derivatives as [11]C-PET imaging agents for β-amyloid plaques. Bioorg Med Chem Lett 2010;20:1976–80.
Medebielle M, Ait-Mohand S, Burkhloder C, Dolbier WR, Laumond G, Aubertin AM. Syntheses of new difluoromethylene benzoxazole and 1, 2,4-oxadiazole derivatives, as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. J Flourine Chem 2005;126:535-54.
Aronoff S, Rosenblatt S, Braithwaite S. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. Diabetes Care 2000;23:1605-11.
Cantello BC, Cawthorne MA, Cottam GP, Duff PT. [[o-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as Potent Antihyperglycemic Agents. J Med Chem 1994;37:3977-85.
Sun LQ, Chen J, Takaki K, Johnson G. Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands. Bioorg Med Chem Lett 2004;14(5):1197-2000.